Pro Medicus
Pro Medicus is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualization solutions. The company's products combine speed, scalability, stability, and smarts to enhance and streamline medical practice management, optimizing efficiency for clinical and administrative staff.
Short position
Pro Medicus (ASX:PME) has 4.12% of its shares on issue reported as short positions as of 5 Oct 2026, or about 4,303,128 shares. Over the past 30 days that figure has fallen 0.22 percentage points, and over 90 days it has fallen 0.95 percentage points. Its highest recorded short interest was 5.46% in October 2020. PME is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Pro Medicus (PME) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $261.6Mvs $212.9M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- $265.3Mvs $115.2M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- $2.54vs $1.10 (FY25)
- Yahoo Finance, as at 29 Sep 2026
- Rev YoY
- +22.9%FY
- EPS YoY
- +130.3%TTM
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- 99.8%
- Operating margin
- 74.9%
- Net margin
- 101.4%
- FCF margin
- 45.4%
- ROE
- 75.0%
- ROA
- 55.9%
- FCF conversion
- 0.45×
- Net cash (excl. leases)
- $216.1M
- Net debt / EBITDA
- −1.1×
- Current ratio
- 6.9×
- Interest cover
- n/a
- Cash dividends paid / net profit
- 24.4%
- Market cap
- $17.31B
- P/E
- 65.4×
- P/B
- 38.4×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $261.6M | $212.9M | $161.4M | $124.8M |
| Gross profit | $261.2M | $212.6M | $161.1M | $124.2M |
| Operating income | $196.0M | $157.6M | $112.2M | $83.8M |
| EBITDA | $204.1M | $164.8M | $120.7M | $91.7M |
| EBIT | $196.0M | $157.6M | $112.2M | $83.8M |
| Pretax income | $377.5M | $163.3M | $116.5M | $86.1M |
| Tax | $112.2M | $48.1M | $33.7M | $25.5M |
| NPAT | $265.3M | $115.2M | $82.8M | $60.6M |
| Net interest income | $9.1M | $7.6M | $4.8M | $2.4M |
| EPS basic | $2.54 | $1.10 | $0.79 | $0.58 |
| EPS diluted | $2.54 | $1.10 | $0.79 | $0.58 |
| Shares | 104.5M | 104.5M | 104.4M | 104.4M |
Financial reports
The company's own filings, newest first
- Annual Report FY26Annual Report18 Aug 2026via asx_announcements
- PME Full Year ResultsFull Year Results18 Aug 2026via asx_announcements
- Preliminary Final Report FY26 (Appendix 4E)Annual Results18 Aug 2026via asx_announcements
- Appendix 4DHalf Year Results12 Feb 2026via asx_announcements
- Half Year AccountsHalf Year Results12 Feb 2026via asx_announcements
- PME AGM Presentation 2025Financial Report31 Dec 2025via crawler
- Preliminary Final report FY25Annual Results14 Aug 2025via asx_announcements
- Annual Report 2025Annual Report14 Aug 2025via asx_announcements
- PME Full Year ResultsFull Year Results14 Aug 2025via asx_announcements
- Half Year Financial StatementsHalf Year Results13 Feb 2025via asx_announcements
Showing 10 of 16 reports